About US
Contact us
>>Back
Echo Therapeutics Develops Prelude SkinPrep System
- Publisher：
- Publication：2010/1/4
As a platform technology for enhanced skin permeation for transdermal drug delivery
Echo Therapeutics has provided updates on the development of its needle-free Prelude SkinPrep System for transdermal drug delivery. The company is developing it as a platform technology for enhanced skin permeation for transdermal drug delivery of a wide range of topical reformulations of widely-used, FDA-approved products.
Echo reiterated its expectation that 2010 will be a transformative year as the company completes the development and regulatory review of its lead products and anticipates generating initial revenues.
Patrick Mooney, chairman and chief executive officer of Echo Therapeutics, said: "Our primary focus is the successful completion of a critical care study with a commercially ready Symphony system, which we believe will be the basis for us to receive FDA approval for Symphony.
“In addition, we anticipate the completion of a clinical trial by Ferndale using the Prelude SkinPrep system for a reduced time and enhanced delivery of lidocaine. This will result in a near-term filing of a 510k application with the FDA. These events will enable us to begin manufacturing scale-up for product validation and planned product launch in 2010."
SOURCE: WEB OF PBR